For the first time, many people in the United States who want to protect themselves against the flu this respiratory virus ...

AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...

FluMist has been approved since 2003, but, until last year, only for administration by a healthcare practitioner. The new nod ...

AstraZeneca PLC closed 13.46% below its 52-week high of £133.88, which the company reached on September 3rd.

Detailed price information for Astrazeneca Plc Ord (AZNCF) from The Globe and Mail including charting and trades.

He said about Britain that the firm needed “to see that there is access and a reason to invest.” This is partly a negotiating ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for AstraZeneca’s ...

AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration — though much of what it is ...

AstraZeneca Vietnam has been recognised as one of the “Best Companies to Work for in Asia 2025” by HR Asia, underscoring its ...

AstraZeneca's oncology sales jump 18% in second-quarter 2025, fueled by key drugs and new launches like Truqap and Datroway.